Merck KGaA (MRK) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Merck KGaA (MRK) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.52 Billion ≈ $1.77 Billion USD) by net assets (€29.00 Billion ≈ $33.90 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Merck KGaA - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Merck KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MRK total debt and obligations for a breakdown of total debt and financial obligations.

Merck KGaA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Merck KGaA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bank Polska Kasa Opieki SA WAR:PEO	0.245x
Jiangsu Zhongtian Technology Co Ltd SHG:600522	0.061x
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk F:PTI	0.080x
Traton SE F:8TRA	0.051x
Unibail-Rodamco-Westfield AU:URW	0.055x
Magna International Inc TO:MG	0.278x
CDW Corp NASDAQ:CDW	0.166x
Beiersdorf Aktiengesellschaft F:BEI	0.019x

Annual Cash Flow Conversion Efficiency for Merck KGaA (2002–2024)

The table below shows the annual cash flow conversion efficiency of Merck KGaA from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see MRK market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€29.99 Billion ≈ $35.06 Billion	€4.59 Billion ≈ $5.36 Billion	0.153x	+8.13%
2023-12-31	€26.75 Billion ≈ $31.28 Billion	€3.78 Billion ≈ $4.42 Billion	0.141x	-13.64%
2022-12-31	€26.00 Billion ≈ $30.40 Billion	€4.26 Billion ≈ $4.98 Billion	0.164x	-24.02%
2021-12-31	€21.42 Billion ≈ $25.04 Billion	€4.62 Billion ≈ $5.40 Billion	0.216x	+5.49%
2020-12-31	€17.02 Billion ≈ $19.89 Billion	€3.48 Billion ≈ $4.06 Billion	0.204x	+28.15%
2019-12-31	€17.91 Billion ≈ $20.94 Billion	€2.86 Billion ≈ $3.34 Billion	0.159x	+23.82%
2018-12-31	€17.23 Billion ≈ $20.15 Billion	€2.22 Billion ≈ $2.59 Billion	0.129x	-32.82%
2017-12-31	€14.07 Billion ≈ $16.44 Billion	€2.70 Billion ≈ $3.15 Billion	0.192x	+6.95%
2016-12-31	€14.05 Billion ≈ $16.43 Billion	€2.52 Billion ≈ $2.94 Billion	0.179x	+4.95%
2015-12-31	€12.86 Billion ≈ $15.03 Billion	€2.20 Billion ≈ $2.57 Billion	0.171x	-25.52%
2014-12-31	€11.80 Billion ≈ $13.80 Billion	€2.71 Billion ≈ $3.16 Billion	0.229x	+14.03%
2013-12-31	€11.07 Billion ≈ $12.94 Billion	€2.23 Billion ≈ $2.60 Billion	0.201x	-15.30%
2012-12-31	€10.41 Billion ≈ $12.18 Billion	€2.47 Billion ≈ $2.89 Billion	0.237x	+95.95%
2011-12-31	€10.49 Billion ≈ $12.27 Billion	€1.27 Billion ≈ $1.49 Billion	0.121x	-29.51%
2010-12-31	€10.37 Billion ≈ $12.13 Billion	€1.78 Billion ≈ $2.08 Billion	0.172x	+19.24%
2009-12-31	€9.51 Billion ≈ $11.12 Billion	€1.37 Billion ≈ $1.60 Billion	0.144x	+35.42%
2008-12-31	€9.62 Billion ≈ $11.25 Billion	€1.02 Billion ≈ $1.20 Billion	0.106x	-24.10%
2007-12-31	€8.69 Billion ≈ $10.16 Billion	€1.22 Billion ≈ $1.42 Billion	0.140x	-34.22%
2006-12-31	€3.81 Billion ≈ $4.45 Billion	€811.70 Million ≈ $948.96 Million	0.213x	-3.11%
2005-12-31	€3.33 Billion ≈ $3.89 Billion	€732.50 Million ≈ $856.37 Million	0.220x	+11.57%
2004-12-31	€2.89 Billion ≈ $3.38 Billion	€570.90 Million ≈ $667.44 Million	0.197x	-38.07%
2003-12-31	€2.36 Billion ≈ $2.76 Billion	€752.40 Million ≈ $879.63 Million	0.318x	+55.07%
2002-12-31	€2.05 Billion ≈ $2.40 Billion	€421.70 Million ≈ $493.01 Million	0.205x	--

About Merck KGaA

XETRA:MRK Germany Drug Manufacturers - Specialty & Generic

Market Cap

$16.53 Billion

€14.14 Billion EUR

Market Cap Rank

#1487 Global

#333 in Germany

Share Price

€109.40

Change (1 day)

-0.59%

52-Week Range

€102.80 - €130.00

All Time High

€220.61